Most of the effects on cell signaling have been detected in the Alzheimer’s disease context and/or in the APP-transgenic mouse models in which the concentrations of Aβ peptides exceed the physiological ones. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.